Previously, a number of authors noted the deletion of the BIRC3 gene in hematological malignancies, in particular in chronic lymphocytic leukemia (CLL), as an unfavorable prognostic marker. Here, BIRC3 is linked to B-cell chronic lymphocytic leukemia.